Evidence map›Paper›PMID 36527501›Full record

ArticleActa diabetologica2023

Increased incidence of type 1 diabetes in 2 years of COVID-19 pandemic.

Carlo Bruno Giorda, Roberto Gnavi, Barbara Tartaglino, Roberta Manti, Alessandro Migliardi, Lucia Favella, Silvia Ferro, Ivana Rabbone

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Acta diabetologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Carlo Bruno GiordaMetabolism and Diabetes Unit, ASL TO5, Regione Piemonte, Chieri, Italy. carlogiordaposta@gmail.com.ORCID 0000-0002-4709-8696
Roberto GnaviEpidemiology Unit, ASL TO3, Regione Piemonte, Grugliasco, Italy.
Barbara TartaglinoChaira Medica Association, Chieri, Italy.
Roberta MantiMetabolism and Diabetes Unit, ASL TO5, Regione Piemonte, Chieri, Italy.
Alessandro MigliardiEpidemiology Unit, ASL TO3, Regione Piemonte, Grugliasco, Italy.
Lucia FavellaDigital Health Department, Information Assets CSI Piemonte, Turin, Italy.
Silvia FerroRegional Heath Service, Farmaceutical Department, Regione Piemonte, Italy.
Ivana RabboneDivision of Pediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy.
CSI Piemonte · ITRegione Puglia · ITMedica (Italy) · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Diabetes Mellitus, Type 1HumansIncidencePandemics

Identifiers

PMID36527501
PMCPMC9759038
OpenAlexW4311718532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.